Categories Uncategorized

Laguna Blends, Inc. (CSE: LAG) (OTC: LAGBF) (LB6A.F) Announces Closing of First Tranche of Private Placement

Before the opening bell, Laguna Blends, Inc. (CSE: LAG) (OTC: LAGBF) (FRANKFURT: LB6A.F) announced a first tranche closing related to its non-brokered private placement. The first tranche closing included the issuance of 1,627,200 units at a price of $0.25 per unit for gross proceeds of $406,800. Each of these units includes one common share, as well as a purchase warrant entitling the holder to acquire an additional common share of Laguna’s stock at a price of $0.40, valid until August 25, 2017. Securities issued as part of the first tranche will be subject to a hold period expiring four months and one day from the original date of issuance. The Canadian Securities Exchange has granted Laguna an extension for the filing of final material related to the private placement to October 7, 2016. The company expects to close the final tranche on or before this date.

In recent weeks, Laguna has remained focused on expanding the reach of its affiliate marketing network across North America. In addition to its innovative beverage products capitalizing on the nutritional health benefits derived from hemp – including Caffe and Pro369 – the company recently entered an exclusive distribution agreement with ISO International, LLC to market, promote and distribute seven cannabidiol (CBD) skin care products developed by Cannaceuticals of California, USA (“Canna”). Through this agreement, Laguna will look to bolster the marketability of its affiliate marketing network with a line of proven skin care products while gaining access to the global skin care industry, which is estimated at $121 billion.

Laguna’s ongoing growth initiatives are being guided by an experienced management team that was recently expanded to include Bryan Loree as chief financial officer, corporate secretary and director. Through this appointment, which was announced early this month, Loree replaced Stuart Gray, the company’s founder and CEO, who was previously serving as acting CFO, adding roughly 10 years of accounting, finance and management experience to the Laguna team.

For more information, visit www.lagunablends.com

About HempWire

HempWire (HW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of journalists and writers, HW is uniquely positioned to best serve private and public companies who need to reach a wide audience of investors, consumers, journalists and the general public. HW has an ever-growing network of more than 5,000 key distribution outlets across the country. By cutting through the overload of information in today’s market, HW brings its clients unparalleled visibility, recognition and brand awareness. HW is where news, content and information converge. For more information, visit www.cannabisnewswire.net.

Please see full disclaimers on the HempWire website: http://nnw.fm/Disclaimer

HempWire (HW)
Denver, CO
www.hempwire.com
303.498.7722 Office
Editor@HempWire.net

Jonathan

Share
Published by
Jonathan

Recent Posts

USDA Says Hemp Harvests, Prices are Rising

A recent report by the U.S. Department of Agriculture points to the hemp industry becoming…

3 days ago

Home Office Overhauls Licensing Framework for Hemp in UK

The Home Office recently made changes to its licensing framework for the industrial hemp industry.…

5 days ago

Lexaria Bioscience Corp. (NASDAQ: LEXX) Marks GLP-1 Study Milestone with Ethics Review Board Approval

Lexaria, a global innovator in drug delivery platforms, has received approval for its GLP-1 human…

6 days ago

Kansas Lawmakers Discuss Proposal to Jail Farmers Growing ‘Hot Hemp’

Local prosecutors in Kansas working in collaboration with one lobbyist and law enforcement are discussing…

1 week ago

Federal Study Finds 9 in 10 Samples of Smokable Hemp Exceed THC Limits

The cultivation and manufacture of hemp has burgeoned since the crop was legalized under the…

2 weeks ago

Lexaria Bioscience Corp. (NASDAQ: LEXX) Grows Global Patent Portfolio to 41; Maintains Focus on GLP-1 Clinical Studies for 2024

Lexaria, a global innovator in drug delivery platforms, has added three new patents to its…

2 weeks ago